The Botulism Antitoxin, cataloged under National Stock Number 6505-01-684-9483, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Emergent Virology, Llc Div Emergent Virology. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-684-9483 |
| Primary Part Number | NDC60492-0075-02 |
| Item Name | Botulism Antitoxin |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Emergent Virology, Llc Div Emergent Virology |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC60492-0075-02 | Emergent Biosolutions Canada Inc (CAN) |
| NDC60492-0075-02 PRIMARY | Emergent Virology, Llc Div Emergent Virology (USA) |
| NDC60492-0075-02 | National Foundation for the Centers for Disease Control & Prevention, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 1561673 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM195830 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-684-9483 is a Botulism Antitoxin, manufactured by Emergent Virology, Llc Div Emergent Virology, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-684-9483 has 3 manufacturer part numbers on file: NDC60492-0075-02 (Emergent Biosolutions Canada Inc), NDC60492-0075-02 (Emergent Virology, Llc Div Emergent Virology), NDC60492-0075-02 (National Foundation for the Centers for Disease Control & Prevention, Inc.).
Key specifications for NDC60492-0075-02: Special Features: MIXTURE OF IMMUNE GLOBULIN FRAGMENTS INDICATED FOR THE TREATMENT OF SYMPTOMATIC BOTULISM FOLLOWING DOCUMENTED OR SUSPECTED EXPOSURE TO BOTULINUM NEUROTOXIN SEROTYPES A, B, C, D, E, F, OR G IN ADULTS AND PEDIATRIC PATIENTS; STORE FROZEN AT OR BELOW 5F (-15C) UNTIL USED; IF FROZEN, THAW VIAL BY PLACING IN A REFRIGERATOR AT 36F TO 46F (2C TO 8C) UNTIL THE CONTENTS ARE THAWED FOR APPROXIMATELY 14 HOURS; ONCE THAWED, THE VACCINE MAY BE STORED AT 2C TO 8C (36F TO 48F) FOR A MAXIMUM OF 36 MONTHS OR UNTIL 48 MONTHS FROM THE DATE OF MANUFACTURE, WHICHEVER COMES FIRST; DO NOT REFREEZE; DO NOT THAW THIS PRODUCT IN A MICROWAVE OVEN; VIALS ARE FOR SINGLE USE ONLY AND CONTAIN NO PRESERVATIVE; DISCARD ANY UNUSED; FOR INTRAVENOUS INJECTION ONLY; DILUTE 1:10 IN 0.9% SODIUM CHLORIDE INJECTION, USP (SALINE) BY ADDING BOTULISM ANTITOXIN SOLUTION FROMTHE VIAL TO THE APPROPRIATE AMOUNT OF SALINE IN AN IV BAG BEFORE ADMINISTERING; DO NOT USE ANY OTHER DILUENTS; 50ML SINGLE DOSE VIAL; PG OF 6 IN; Part Name Assigned by Controlling Agency: BOTULISM ANTITOXIN HEPTAVALENT, 6 VIALS, 50 ML. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.